MARKET

KOD

KOD

Kodiak Sciences Inc.
NASDAQ
3.580
+0.045
+1.27%
Opening 13:01 05/22 EDT
OPEN
3.480
PREV CLOSE
3.535
HIGH
3.700
LOW
3.360
VOLUME
166.42K
TURNOVER
--
52 WEEK HIGH
11.60
52 WEEK LOW
1.920
MARKET CAP
188.89M
P/E (TTM)
-0.9887
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KOD last week (0512-0516)?
Weekly Report · 3d ago
Cautious Hold Rating on Kodiak Sciences Amid Strategic Developments and Past Trial Challenges
TipRanks · 3d ago
Kodiak Sciences Shares Drop After Wider-Than-Expected 1Q Loss
Dow Jones · 6d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 05/15 17:06
Kodiak Q1 Loss Wider Than Expected, Pipeline Development in Focus
Barchart · 05/15 11:20
Kodiak Sciences GAAP EPS of $1.09 beats by $1.99
Seeking Alpha · 05/14 21:28
Kodiak Sciences Q1 EPS $(1.09) Misses $(0.87) Estimate
Benzinga · 05/14 20:30
Kodiak Sciences reports Q1 EPS ($1.09), consensus (87c)
TipRanks · 05/14 20:22
More
About KOD
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab tedromer, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy and wet age-related macular degeneration. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate designed to inhibit interleukin-6 (IL-6)-mediated inflammation and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.

Webull offers Kodiak Sciences Inc stock information, including NASDAQ: KOD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KOD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KOD stock methods without spending real money on the virtual paper trading platform.